LEG
36
4
MET
72
5
MRK
25
-2
INTU
56
-4
HPE
63
2
TRIP
47
3
ZION
65
2
HD
57
2
PBI
69
4
URBN
56
14
WEC
53
-2
GOOGL
40
-5
MPC
44
-3
FE
50
-2
PLD
56
8
WY
54
4
DOW
44
10
CF
57
-2
LRCX
43
-2
LB
63
22
LEG
36
4
MET
72
5
MRK
25
-2
INTU
56
-4
HPE
63
2
TRIP
47
3
ZION
65
2
HD
57
2
PBI
69
4
URBN
56
14
WEC
53
-2
GOOGL
40
-5
MPC
44
-3
FE
50
-2
PLD
56
8
WY
54
4
DOW
44
10
CF
57
-2
LRCX
43
-2
LB
63
22
Financhill
Back

Structure Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
32

GPCR
Structure Therapeutics

Last Price:
33.44
Seasonality Move:
-14.82%
Sell
40

NVO
Novo Nordisk AS

Last Price:
105.10
Seasonality Move:
10.2%
Sell
32
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $33.41. The Score for GPCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $105.06. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $33.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 41.58 Sell
Chaikin Money Flow: 882035 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.2 - 39.9) Sell
Bollinger Bands (100): (35.54 - 41.32) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.67 Sell
Relative Strength Index (14 RSI): 41.39 Sell
Chaikin Money Flow: 49323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.22 - 113.68) Sell
Bollinger Bands (100): (113.16 - 136.4) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.62 Sell
20-day SMA: 36.75 Sell
50-day SMA: 38.81 Sell
200-day SMA: 39.76 Sell
8-day EMA: 33.58 Sell
20-day EMA: 35.75 Sell
50-day EMA: 37.61 Sell
200-day EMA: 39.17 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.67 Buy
20-day SMA: 107.35 Sell
50-day SMA: 115.47 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.35 Buy
20-day EMA: 107.36 Sell
50-day EMA: 114.34 Sell
200-day EMA: 120.49 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):